Gerresheimer consensus earns attention, shares trade higher on Xetra

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 20:10.

Gerresheimer (DE000A0LD6E6) stands out today with a clear analyst consensus and a noticeable valuation gap to the average target price. The MDAX-listed packaging specialist sees its shares trading higher on Xetra, while the consensus points to a Hold stance with limited upside according to MarketScreener data.

What the analysts are saying

Analyst coverage for Gerresheimer currently aggregates to a mean consensus rating of Hold, based on 12 contributing analysts tracked by MarketScreener. The latest compiled figures show an average target price of 23.37 euros, compared with a recent close around 25.90 euros, implying a negative spread of roughly 9.76 percent versus the consensus target.

Jefferies most recently adjusted its stance on Gerresheimer in May 2026, downgrading the stock from Buy to Hold and setting a price target at 26.80 euros, slightly above the current consensus but close to where the shares are trading today. This move underscores a more cautious tone among coverage houses and underlines that recent share gains have already priced in part of the expected fundamental progress.

How the shares trade today

On Xetra, Gerresheimer shares last changed hands at 26.84 euros in delayed trading, showing a gain of 0.94 euros or about 3.63 percent compared with the previous session, according to quote data on Onvista. Trading indications from Stuttgart and Tradegate point to similar levels just below 27 euros, with intraday moves around four percent up in early dealings, suggesting that investors have been willing to pay above the consensus target range.

Gerresheimer is a member of the MDAX index on the Frankfurt Stock Exchange, positioning it among Germany's mid-cap industrial and healthcare names with steady institutional coverage. The combination of MDAX membership, a Hold consensus and a share price above the average target price creates a valuation tension that fundamental investors will watch closely in the coming weeks.

The business behind the stock

Gerresheimer generates its revenue as a specialist provider of packaging and delivery systems for pharmaceuticals and cosmetics. The company’s core offerings include glass and plastic primary packaging, such as vials and bottles, and complex drug-delivery devices for injectable and inhalable medicines, serving global pharma and biotech customers. This focus on regulated healthcare end markets supports recurring demand patterns and positions the group within the broader medical technology and packaging segment.

Where the stock trades today

The Gerresheimer shares (DE000A0LD6E6) trade on Xetra at 26.84 euros as of 2026-06-23, 08:14, based on delayed quote data, with similar levels indicated on Stuttgart and Tradegate in euros.

This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a substitute for professional financial consultation. Data and prices are based on sources cited and may change during trading.